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ABSTRACT
Thymic atrophy occurs during infection being associated with apoptosis of double 
positive (DP) and premature exit of DP and double negative (DN) thymocytes. We 
observed for the first time that a significant bone marrow aplasia and a decrease in 
common lymphoid progenitors (CLPs) preceded thymic alterations in mice infected 
with Trypanosoma cruzi. In addition, depletion of the DN2 stage was previous to 
the DN1, indicating an alteration in the differentiation from DN1 to DN2 thymocytes. 
Interestingly, infected mice deficient in IL-6 expression showed higher numbers 
of DP and CD4+ thymocytes than wild type infected mice, while presenting similar 
percentages of DN1 thymocytes. Moreover, the drop in late differentiation stages of 
DN thymocytes was partially abrogated in comparison with wild type littermates. 
Thus, our results suggest that thymic atrophy involves a drop in CLPs production 
in bone marrow and IL-6-dependent and independent mechanisms that inhibits the 
differentiation of DN thymocytes.
INTRODUCTION
Thymic involution and decreased thymopoiesis are 
highly related simultaneous events. During this process 
the size and function of the thymus is drastically reduced 
(up to 95%) which can be triggered by several processes 
such as aging [1], pregnancy [2] or stress [3]. Thymic 
involution is observed also during infection, existing two 
main hypothesis about its advantages and disadvantages, 
as the prevention of tolerance against pathogen’s antigens 
[4], and as a cause of immunosuppression [5], respectively. 
The maturing T cells (thymocytes) can be classified 
(according to CD4 and CD8 markers expression) in the 
following major stages: about 5% are double negative 
(DN) thymocytes, 80% are double positive (DP) 
thymocytes, 10% are CD4 single positive (SP) and 
5% are CD8 SP [6]. T cell development in the thymus 
progresses from DN to DP and finally to CD4 or CD8 SP 
[7]. In addition, DN thymocytes can be subdivided in 4 
stages (from DN1 to DN4) characterized by differential 
expression of CD25 and CD44 markers. 
During the acute phase of Trypanosoma cruzi 
infection, the causal agent of Chagas disease, the thymus 
undergoes an involution that has been associated to a 
drastic reduction of DP thymocytes in the thymus [8]. 
Several mechanisms, which are not mutually exclusive, 
can alter normal thymic development and explain this 
involution: (I) the mobilization of DP thymocytes to 
peripheral organs, as detected by observing DP T cells in 
secondary lymphoid organs [9, 10], (II) apoptotic death 
of DP thymocytes [11] that has been linked to various 
causes such as trans-sialidase activity of the parasite 
[12] extracellular ATP [13] or dysregulation of positive 
selection due to excessive production of glucocorticoids 
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[14] and (III) premature exit of DN cells from the thymus 
[15]. Moreover, bone marrow B cell maturation is also 
altered during T. cruzi infection [16].
On the other hand, we previously observed DP 
depletion in mice susceptible and non-susceptible to T. 
cruzi infection, being the susceptibility associated with 
high levels of IL-6 in plasma [17]. Interestingly, IL-6 has 
also been involved in some cases of thymus atrophy, as 
thymic depletion due to age [1] or fetal thymic atrophy 
caused by LPS treatment [18], indicating a possible link 
between IL-6 and thymic alterations.
IL-6 is mostly produced in the thymus by mature I-A 
and Mac-1 positive accessory cells [19], and by thymic 
epithelial cells (TECs) [20]. IL-6 has been described to act 
both as an anti- and pro-inflammatory cytokine, depending 
on its receptor binding. After IL-6 binding to the IL-6α 
receptor (IL-6Rα) it subsequently binds to the IL-6Rβ 
(gp130) receptor, and there is increased proliferation 
and inhibition of apoptosis, a process known as classic-
signaling [21]. On the contrary, sometimes a soluble 
form of the IL-6R is shed from the membrane and binds 
to IL-6 which can interact directly on cells expressing 
membrane gp130, but not IL-6R, activating a signaling 
pathway known as trans-signaling [21].The later exerts a 
pro-inflammatory role, activating the immune system at 
several levels as recruitment of mononuclear cells through 
CCL2, inhibition of T-cell apoptosis and inhibition of 
regulatory T cell differentiation [21]. 
In view of the above, we studied whether (I) a 
decrease in thymocyte bone marrow precursors could 
influence the levels of thymic populations and (II) that 
IL-6 induced by infection alter thymocyte differentiation 
contributing to thymic atrophy. We found a significant 
decrease in bone marrow CLPs and DN1 thymocyte stage, 
both independent of IL-6, prior to any other alteration in 
the thymus. Notably, we also describe for the first time 
that T. cruzi infection altered DN1 to DN2 stage transition 
leading to deficient thymocyte differentiation. This effect 
was dependent on IL-6, since it was partially abrogated 
in mice deficient in IL-6 expression. Moreover, IL-6 
deficient mice showed lower thymic depletion than wild 
type animals after infection. 
RESULTS
Bone marrow aplasia and CLPs in T. cruzi 
infected mice
Mice infected with T. cruzi showed high levels of 
parasitemia between days 7 and 21 after infection (Figure 
1A). We first examined the status of the major and primary 
hematopoietic organ, the bone marrow, during the acute 
phase of infection. Bone marrow total cell numbers 
were significantly decreased at day 13 post-infection 
and recovered the basal levels, by day 21 post-infection 
(Figure 1B). Linneg Sca-1neg c-Kitmed corresponding to 
common lymphocyte precursors (CLPs) analysis showed 
that cell percentages in bone marrow of infected mice 
did not significantly change respect non-infected mice 
(Supplemental Figure 1A). However, accordingly with 
total bone marrow cell numbers, we found a significant 
decrease in CLPs numbers at 13 and 21 d.p.i. (Figure 
1C) that reached levels above the basal by day 35 post-
infection. These results suggest that bone marrow aplasia 
and CLPs low numbers can contribute to thymic atrophy.
Dynamics of thymocyte stages in T. cruzi infected 
mice
We next analyzed the cellularity in the thymus. 
Thymocyte numbers significantly increased by day 7 
Figure 1: Bone marrow cells and CLPs during T. cruzi infection. BALB/c mice were infected with T. cruzi, bone marrow cells 
and thymocytes were obtained at different days post-infection and counted under microscopical examination in Neubauer chambers. A. 
Number of trypomastigotes per ml of blood during T. cruzi infection. B. Total number of bone marrow cells. C. Total number of CLPs was 
determined by analyzing Linneg cells, Sca-1neg c-Kitmed. A representative experiment out of two independent experiments is shown. One way 
ANOVA tests were performed to determine the significance of the results (n = 3; * p < 0.05; **p < 0.01; ***p < 0.001). 
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post-infection but dropped significantly at 13, 16, 21 and 
35 days post-infection (d.p.i.) (Figure 2A). As previously 
observed [17, 22], analysis of thymic differentiation 
of DN, DP and SPs thymocytes regarding CD4 and 
CD8 markers during the acute infection, showed a huge 
decrease in the percentages (Figure 2B and 2C) and total 
numbers (Figure 2D) of DP thymocytes, starting at 13 
d.p.i. and partially recovering later in infection. As for 
total thymocytes (Figure 2A) at day 7 post-infection the 
number of DP and SP thymocytes showed an increment 
in total cell numbers (Figure 2D). Notably, total DN 
thymocyte numbers, but not percentages, significantly 
decreased upon infection, being this discrepancy due to 
the huge decrease in the major DP populations (Figure 2B, 
2C and 2D). On the other hand, the relative percentages of 
both CD4+ and CD8+ SPs thymocytes were increased at 13, 
16 and 21 d.p.i. also likely due to the severe depletion of 
DP cells (Figure 2B and 2C), but total numbers dropped 
dramatically at 21 and 35 d.p.i. (Figure 2D). Thymocyte 
populations tend to recover at 35 d.p.i., likely indicating a 
transition to the chronic phase of infection.
Alteration of DN thymocyte development in T. 
cruzi infected mice
We next analysed the dynamics of double negative 
stages with the CD25 and the CD44 markers on Linneg 
Figure 2:  Thymic DN, DP and SP stages during T. cruzi infection. BALB/c mice were infected with T. cruzi, thymus were obtained 
at different days post-infection and analyzed by Flow Cytometry as described in material and methods. A. Total thymocyte numbers. B. Dot 
plot analysis of thymic cells from representative mice based on CD4 and CD8 markers showing DN, DP, CD4+ and CD8+stage percentages 
at different d.p.i. C. Graphs representing mean ± SEM of the percent of DN, DP, CD4+ and CD8+ thymocyte percentages at different d.p.i.. 
D. Graphs representing the total number of each DN, DP, CD4+ and CD8+ thymocyte stages at different d.p.i. A representative experiment 
out of six independent experiments is shown. One way ANOVA tests were performed to determine the significance of the results (n = 3; * 
p < 0.05; **p < 0.01; ***p < 0.001).. 
Oncotarget17554www.impactjournals.com/oncotarget
thymocytes to track the stages of DN thymocytes (DN1, 
DN2, DN3 and DN4) during infection using the gating 
strategy shown in supplemental Figure 1B. Interestingly, 
we observed that the percentages of DN2, DN3 and DN4, 
but not DN1, thymocytes decreased during acute T. cruzi 
infection until day 21 (Figure 3A and 3B), suggesting an 
alteration at this point in thymocyte differentiation caused 
by acute infection. However, a severe drop in total cell 
numbers of DN stages including DN1 was observed. 
Indeed, DN2, DN3, and DN4 cell numbers were reduced 
from day 10 post-infection and by more than 90% at 
16 and 21 d.p.i. In contrast, the reduction of DN1 cell 
numbers was proportionally lower and occurred later (16 
and 21 d.p.i.) than DN2-DN4 reduction (Figure 3C).
IL-6 mediates a blockade in DN thymocyte 
differentiation in T. cruzi infected mice
We previously observed that T. cruzi infection 
caused the increase in the levels of Il6 mRNA expression 
in heart tissue and IL-6 in plasma, associated with higher 
pathology [17]. To address the role of IL-6 in thymocyte 
differentiation during infection, we first analysed the 
Figure 3: Thymic DN1-DN4 stages during T. cruzi infection. BALB/c mice were infected with T. cruzi, thymus were obtained at 
different days post-infection and analyzed by Flow Cytometry as described in material and methods. A. Dot plot analysis of thymic cells 
from representative mice based on CD25 and CD44 markers showing DN1, DN2, DN3 and DN4 thymocyte stage percentages at different 
d.p.i. B. Graphs representing mean ± SEM of the percent of DN1-4 thymocyte stages at different d.p.i. C. Graphs representing the total 
number of each DN thymocyte stage at different d.p.i. A representative experiment of two independent experiments is shown. One way 
ANOVA tests were performed to determine the significance of the results, (n = 3; * p < 0.05; **p < 0.01; ***p < 0.001).
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mRNA gene expression of IL-6 and its receptors in the 
thymus. The results showed a significant increase of IL-6 
(Il6) at 14 and 21 d.p.i. and IL-6Rα (Il6ra), but not IL-6Rβ 
(Il6st), at 21 d.p.i. (Figure 4).
To better elucidate the possible involvement of 
IL-6 in thymic alterations caused by T. cruzi infection 
we analysed this in IL-6 deficient (IL-6-/-) mice. Both 
IL-6+/+ and IL-6-/- infected mice showed similar levels of 
parasitemia around 10 d.p.i. (Figure 5A). IL-6+/+(C57BL/6) 
mice, as in BALB/c mice (Figure 2), presented a severe 
drop in total thymic cells upon T. cruzi infection (Figure 
5B, black bars), as well as a huge reduction in DP and 
DN and increases in CD4+ SP total numbers (Figure 
5D, black bars), indicating that there were no major 
differences between BALB/c and C57BL/6 strains, as 
we previously described [17]. Interestingly, analysis of 
thymocyte subpopulations (Supplemental Figure 1B) 
in infected IL-6-/- mice showed significant differences 
respect to infected IL-6+/+mice (Figure 5 and 6, gray bars). 
Although a decrease in total thymocyte numbers was also 
observed in infected IL-6-/- mice, this was significantly less 
pronounced than in IL-6+/+ mice, since more than twice 
the numbers of thymocytes were recovered from T. cruzi-
infected IL-6-/- mice (Figure 5B). Significant changes in 
the percentages of DP were detected between both strains 
of mice (Figure 5C and 5D). Notably, DP percentages and 
cell numbers were significantly higher in IL-6-/- compared 
to IL-6+/+ infected mice (Figure 5D). 
Interestingly, there were significantly higher DN 
thymocyte percentages and numbers in IL-6-/- mice 
compared to IL-6+/+ mice (Figure 6A-6C). However, a 
significant DN total cell number reduction was observed 
in both IL-6-/- and IL-6+/+ infected mice respect uninfected 
in all the stages analysed (Figure 5E), indicating an effect 
prior to DN1 that was IL-6-independent.
Apoptosis of thymocytes during T. cruzi infection
Apoptosis is one of the mechanisms responsible 
for thymic atrophy, thus we performed TUNEL assays on 
thymic sections from infected BALB/c mice. The results 
showed a significant increase of apoptotic thymocytes 
at 21 d.p.i (Figure 7A). In addition, the levels of 
corticosterone, which induce thymocyte apoptosis [23], 
were significantly increased at 21 d.p.i. (Figure 7B). Thus, 
the results indicate that thymocyte apoptosis is likely 
increased by circulating glucocorticoids (corticosterone).
DISCUSSION
Our results show for the first time that the decreased 
numbers of lymphocyte bone marrow precursors 
determines in a great extent the drop in the number of DN 
thymic populations after T. cruzi infection. In addition, 
studies in IL-6-/- mice, revealed the involvement of IL-6 in 
decreasing the number of DN2 thymocytes after infection. 
Hence, both phenomena likely contribute to the drop of 
DP and SP thymocytes and thymic atrophy observed 
during infection. 
Thymic atrophy during T. cruzi infection has been 
associated with premature DP and DN egress from the 
thymus to peripheral lymphoid organs [10, 12, 23], as well 
as apoptosis of DP thymocytes [24]. However, the effect 
of infection on bone marrow thymocyte precursors and 
DN thymocyte stages had never been reported before.
Figure 4: mRNA gene expression in thymus of mice infected with T. cruzi. BALB/c mice were infected with T. cruzi, thymus 
were obtained at different days post-infection and analyzed by RTqPCR as described in materials and methods. Gene expression of Il6, 
Il6ra (IL-6 receptor α), Il6st (IL-6 receptor β or gp130), was analyzed and relative quantities (RQ) were normalized respect non-infected 
mice. Graphs represent mean ± SEM values. A representative experiment out of two independent experiments is shown. Student t-tests were 
performed to determine the significance of the results in infected versus non-infected mice. (n = 3; * p < 0.05; **p < 0.01; ***p < 0.001). 
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Figure 5: Effect of IL-6 on thymic DN, DP and SP stages during T. cruzi infection. IL-6+/+ and IL-6-/- mice were infected with T. 
cruzi, thymus were obtained at 18 days post-infection and analyzed by Flow Cytometry as described in material and methods. A. Number 
of trypomastigotes per ml of blood during T. cruzi infection. B. Total number of thymocytes at different d.p.i. C. Dot plot analysis of thymic 
cells from representative mice based on CD4 and CD8 markers showing DN, DP, CD4+ and CD8+ thymocyte stage percentages. Graphs 
representing mean ± SEM of the percent of each thymocyte population. D. Graphs representing the total number of each DN, DP, CD4+ 
and CD8+thymocyte stages. A representative experiment out of two independent experiments is shown. Student t-tests were performed to 
determine the significance of the results (n = 3; * p < 0.05; **p < 0.01; ***p < 0.001). 
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The bone marrow aplasia and decrease in bone 
marrow CLP numbers observed were temporarily 
coincident with the thymic atrophy.
These lymphopoietic alterations occurred prior 
to the increase in the apoptosis of DP thymocytes. 
Furthermore, infection also altered earliest steps of 
thymocyte differentiation in the thymus as the transition 
from DN1 to DN2 stages. This was suggested by a 
reduction in the percentages of DN2, DN3 and DN4, 
but not DN1, thymocytes and by an earlier and stronger 
reduction after infection of DN2, DN3 and DN4 respect to 
DN1 total cell numbers.
Figure 6: Effect of IL-6 on thymic DN1-DN4 stages during T. cruzi infection. IL-6+/+ and IL-6-/- mice were infected with T. 
cruzi, thymus were obtained at 18 days post-infection and analyzed by Flow Cytometry as described in material and methods. A. Dot plot 
analysis of thymic cells from representative mice based on CD25 and CD44 markers showing DN1, DN2, DN3 and DN4 stage percentages. 
B. Graphs representing mean ± SEM of the percent of DN1-4 thymocyte stages. C. Graphs representing the total number of each DN 
thymocyte stage. A representative experiment out of two independent experiments is shown. Student t-tests were performed to determine 
the significance of the results (n = 3; *p < 0.05; **p < 0.01; ***p < 0.001). 
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We also observed thymocyte apoptosis after T. cruzi 
infection as described [11], but with maximal activity 
after the alteration in transition from DN1 to DN2. Thus, 
probably both mechanisms converge and conduce to 
thymocyte depletion but with different kinetics.
Notably, all DN thymocyte populations returned to 
the basal levels at 35 d.p.i., likely indicating a transition 
to the chronic phase of infection, in which the thymus 
environment is restored.
Surprisingly, we observed an increase in total thymic 
cell numbers, DP and SP, but not in DN thymocytes, at 
7 d.p.i., suggesting that thymopoiesis was somehow 
stimulated at the beginning of the infection, an issue that 
deserves further investigation in the future. However, DP 
cell numbers subsequently decreased in agreement with 
previous observations [17]. Interestingly, this drop took 
place later than DN reduction.The decrease in DN and 
DP precursors is likely affecting CD4+ and CD8+ numbers 
that could compromise the T cell immune response [6]. 
Another remarkable finding is that the decrease in both 
CD4+ and CD8+ SPs thymocyte numbers was observed 
at 21 and 35 days post-infection, much later than the 
decrease in DP (13 d.p.i.). The reason for this is unclear. It 
may indicate that CD4+ and CD8+ SPs remain healthy in 
the thymus for at least 7 days without dying by apoptosis 
and/or being exported to the periphery as a consequence 
of its normal development. In this regard, the average 
life-span of SP in the thymus, is around 12 days for 
both CD4+ and CD8+ subpopulations [25]. Together, this 
suggests a minimal direct effect of infection on SP, being 
the observed effects likely secondary to DN-DP dynamics 
and their own life span.
Here, we found a significant increase in Il6 
mRNA as previously observed in heart tissue and its 
protein in plasma of infected mice [17]. In addition, 
there was a significant increase of Il6ra mRNA, but not 
Il6st mRNA, above to the basal levels. However, basal 
levels of expression of Il6, Il6st and Il6ra in the thymus 
were high as evidenced by ∆CT values around 19, 11 
and 10, respectively. These lead us to hypothesize that 
IL-6 is triggering inflammation in the thymus, affecting 
differentiation from DN1 to DN2 stage.
In agreement with this hypothesis, we found that 
IL-6-/- andIL-6+/+ infected mice presented similar depletion 
of DN1 stage cell numbers compared to uninfected mice, 
indicating that this does not depend on IL-6. Notably, 
there were higher numbers of DN2 and DN3 stages in 
IL-6-/- infected mice compared to IL-6+/+ mice. Thus, the 
inhibition of the DN1 to DN2 transition caused by T. cruzi 
infection is likely to be mediated by IL-6.
It has been recently described that Sphingosine-1-
phosphate receptor 1 (S1P1R)-mediates DN premature 
exit from the thymus since it was completely abrogated 
in S1P1R deficient mice [15]. Thus, the partial restoration 
of thymocyte stages observed in our IL-6-/- infected mice 
model suggests that premature DN exit from the thymus 
cannot be completely attributed to IL-6.
As mentioned, many mechanisms were described 
to explain the thymic atrophy observed during T. cruzi 
infection. The significant increment in corticosterone 
Figure 7: Apoptosis in thymocytes after T. cruzi infection. BALB/c mice were infected and thymocytes and plasma were isolated 
as described in materials and methods. A. Apoptosis of thymocytes at 0, 7, 14, 21, 28 and 35 days post-infection was determined by flow 
cytometry by TUNEL assay as described in materials and methods. A representative experiment out of two independent experiments is 
shown. Student t-tests were performed to determine the significance of the results (n = 3; *p < 0.05). B. Corticosterone in plasma was 
determined in one experiment by Metabolon Inc. at 0 and 21 d.p.i. Student t-tests were performed to determine the significance of the results 
(n = 6; *p < 0.05).
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levels we found is in agreement with the alterations on the 
hypothalamus-pituitary-adrenal (HPA) axis and endocrine 
homeostasis described during T. cruzi infection [26], that 
cause apoptosis of DP thymocytes. Moreover, blockade 
of glucocorticoid receptor activity prevented thymocyte 
apoptosis [11]. However, it occurred later than the bone 
marrow lymphopoietic defect and the alteration in DN 
differentiation.
Thus, the mechanism of T. cruzi thymic involution 
and dysfunction is likely to be multifactorial. Based on 
these results, we propose a dynamic model in which there 
is first an increase in the thymopoiesis, being the reason 
for that unknown. Later, a decrease in CLPs generation 
in the bone marrow may have a negative impact in all 
thymocyte stages. In addition, excessive IL-6 production, 
systemically and locally in the thymus may affect DN1 
to DN2 transition. Finally, the additive effects on bone 
marrow precursor deficiency and IL-6 effect on DN1 to 
DN2 transition, combined with glucocorticoid-dependent 
thymocyte apoptosis and other mechanisms of thymocyte 
depletion, as premature DP and/or DN exit, would cause 
the severe drop on DP thymocytes. In summary, our 
results add further levels of complexity that will help 
to better understand thymic atrophy not only in T. cruzi 
infection. Finally, similar defects in DN differentiation 




Female BALB/c mice (6 to 8-week-old) were 
purchased from Harlan-InterfaunaIberica and Charles 
River Laboratories España, and maintained at the Centro 
de Biología Molecular Severo Ochoa (CBMSO, CSIC-
UAM, Madrid, Spain) animal facility. IL-6-knockout (IL-
6-/-; B6.129S2-Il6 < tm1Kopf > /J) and C57BL/6J wild 
type mice were obtained from the Jackson Laboratory, 
Bar Harbor, ME, USA, and were maintained at the Animal 
Resource Facility of the CIBICI-CONICET (Argentina).
In vivo infections were performed with Y T. cruzi 
strain as described [27, 28]. Mice were infected with 
2,000 blood trypomastigotes per mice by intraperitoneal 
injection. For BALB/c mice at 0, 7, 10 and 13 d.p.i., 3 
mice were infected per experimental group. However, 
at 16, 21 and 35 d.p.i. the number of infected mice per 
experimental group was increased up to 15 in order to 
get at least 3 surviving mice in each experimental group 
that were analyzed. For IL-6+/+ and IL-6-/- mice at 0 and 
18 d.p.i. 3 mice were infected per group. All experiments 
were performed two times. Survival was monitored daily 
and parasitemia levels were checked every 2-3 days. Mice 
blood and tissues were collected at the indicated days post-
infection (d.p.i.). 
Ethics statement
This study was carried out in strict accordance with 
the European Commission legislation for the protection 
of animals used for scientific purposes (Directives 
86/609/EEC and 2010/63/EU). Mice were maintained 
under pathogen-free conditions at the CBMSO (CSIC-
UAM) animal facility. The protocol for the treatment of 
the animals was approved by the ‘‘Comité de Ética de 
Investigación de la Universidad Autónoma de Madrid’’, 
Spain (permits CEI-14-283 and CEI-47-899). Experiments 
performed in Argentina followed the recommendations 
from the Guide for the Care and Use of Experimental 
Animals (Canadian Council on Animal Care) and 
approved by the National University of Cordoba and 
CIBICI-CONICET, Argentina. Animals had unlimited 
access to food and water. They were euthanized in a CO2 
chamber and all efforts were made to minimize their 
suffering.
Flow cytometry analysis
Flow cytometry was performed as previously 
described [28]. Briefly, FcγRs were blocked with anti 
CD16/CD32 antibody (Fc block) prior to staining with 
antibodies coupled to fluorophores. The flow cytometry 
staining antibodies used are listed in Supplementary 
Table 1. Bone marrow cells were isolated and stained 
with antibodies against Lineage markers (Lin: anti-CD4, 
anti-CD8, anti-B220, anti-Ter119, anti-CD11b, anti-Gr-1 
and anti-DX5), Then lineage negative (Linneg) gated 
cells were analyzed using Sca-1 and c-Kit markers, and 
CLPs identified as Linneg Sca1neg c-Kitmed. Thymocytes 
were isolated and stained with anti-CD4-CD8-CD25-
CD44 antibodies. Analysis of DN, DP and SP stages was 
performed based on CD4 and CD8 staining, and DN1 
to DN4 stages based on CD25 and CD44 staining on 
the Linneg gated population. Samples were analyzed in a 
FACS Canto II Cytometer (Becton Dickinson) using the 
FlowJo software (Tree Star, Inc. Oregon Corporation). The 
compensation controls of the labeled antibodies are shown 
in Supplemental Figure 2.
mRNA analysis by quantitative reverse 
transcription PCR
For RNA extraction, thymuses were elicited and 
thymocytes suspensions obtained after mechanical 
disruption utilizing 40-µm mesh cell strainers (Falcon) 
and bone marrow cells were isolated from mice femurs. 
mRNAs were isolated utilizing TRIzol reagent (Invitrogen) 
as indicated by the manufacturer. Gene expression of IL-6 
Oncotarget17560www.impactjournals.com/oncotarget
(Il6) or its receptor was analyzed by quantitative reverse 
transcription PCR (RTqPCR). Reverse transcription 
of total RNA was performed using the components of 
the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems). Amplifications were performed 
using oligonucleotide probes (Supplementary Table 
2) and the GoTaq qPCR MAster Mix (Promega) on an 
ABI PRISM 7900 HT instrument (Applied Biosystems). 
All samples were assayed in triplicate. Quantification of 
gene expression by real-time PCR was calculated by the 
comparative threshold cycle (CT) method as described in 
[29] (RQ = 2-ΔΔCT). All quantifications were normalized to 
the ribosomal 18S control to account for the variability 
in the initial concentration of RNA and in the conversion 
efficiency of the reverse transcription reaction.
TUNEL assay
Thymocytes were isolated from BALB/c mice at 
different days post-infection and processed with the In 
situ cell detection kit, TMR red (Roche) following the 
directions of the manufacturer and analyzed in a FACS 
Canto II Cytometer (Becton Dickinson) using the FlowJo 
software (Tree Star, Inc. Oregon Corporation).
Corticosterone relative levels in plasma
Corticosterone relative levels were determined 
in mouse plasma by Metabolon Inc. using gas 
chromatography (GC)/mass spectrometry (MS) and 
liquid chromatography (LC)/MS platforms, raw data was 
normalized and results expressed as ScaledImpData as 
previously described [30]. 
Statistical analysis
Data is shown as mean ± SEM. Statistical 
significance was evaluated by Student’s t-test when two 
groups were compared, and one way ANOVA, followed 
by Tukey post-test, when different times were evaluated 
in an experimental group, using the GraphPad Prism 5.00 
software (La Jolla, CA, USA).
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